Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-27

Clinical Trial Update: Treatment of Angiotensin Converting Enzyme Inhibitor-induced Angioedema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment for angioedema caused by ACE inhibitors has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor | Phase 2 | Status: TERMINATED | Results posted: 2024-03-27